58 related articles for article (PubMed ID: 14613396)
1. Understanding the impact of asthma in the 21st century.
Turk A
J Manag Care Pharm; 2002; 8(5 Suppl):3-7. PubMed ID: 14613396
[TBL] [Abstract][Full Text] [Related]
2. Current approaches to asthma management: assessing clinical and economic evidence.
O'Connor RD
J Manag Care Pharm; 2002; 8(5 Suppl):8-17. PubMed ID: 14613397
[TBL] [Abstract][Full Text] [Related]
3. Guidelines for the emergency management of asthma in adults. CAEP/CTS Asthma Advisory Committee. Canadian Association of Emergency Physicians and the Canadian Thoracic Society.
Beveridge RC; Grunfeld AF; Hodder RV; Verbeek PR
CMAJ; 1996 Jul; 155(1):25-37. PubMed ID: 8673983
[TBL] [Abstract][Full Text] [Related]
4. Effects of fluticasone propionate/salmeterol combination on asthma-related health care resource utilization and costs and adherence in children and adults with asthma.
Delea TE; Hagiwara M; Stanford RH; Stempel DA
Clin Ther; 2008 Mar; 30(3):560-71. PubMed ID: 18405796
[TBL] [Abstract][Full Text] [Related]
5. Use of the health plan employer data and information set for measuring and improving the quality of asthma care.
Gelfand EW; Colice GL; Fromer L; Bunn WB; Davies TJ
Ann Allergy Asthma Immunol; 2006 Sep; 97(3):298-305. PubMed ID: 17042134
[TBL] [Abstract][Full Text] [Related]
6. The utility of the Health Plan Employer Data and Information Set (HEDIS) asthma measure to predict asthma-related outcomes.
Berger WE; Legorreta AP; Blaiss MS; Schneider EC; Luskin AT; Stempel DA; Suissa S; Goodman DC; Stoloff SW; Chapman JA; Sullivan SD; Vollmer B; Weiss KB
Ann Allergy Asthma Immunol; 2004 Dec; 93(6):538-45. PubMed ID: 15609762
[TBL] [Abstract][Full Text] [Related]
7. Cross-sectional analysis of the relationship between national guideline recommended asthma drug therapy and emergency/hospital use within a managed care population.
Nestor A; Calhoun AC; Dickson M; Kalik CA
Ann Allergy Asthma Immunol; 1998 Oct; 81(4):327-30. PubMed ID: 9809496
[TBL] [Abstract][Full Text] [Related]
8. Inhaled corticosteroid use and outcomes in pregnancy.
Schatz M; Leibman C
Ann Allergy Asthma Immunol; 2005 Sep; 95(3):234-8. PubMed ID: 16200813
[TBL] [Abstract][Full Text] [Related]
9. Retrospective claims study of fluticasone propionate/salmeterol fixed-dose combination use as initial asthma controller therapy in children despite guideline recommendations.
Friedman HS; Eid NS; Crespi S; Wilcox TK; Reardon G
Clin Ther; 2009 May; 31(5):1056-63. PubMed ID: 19539106
[TBL] [Abstract][Full Text] [Related]
10. Resource utilization in asthma: combined fluticasone propionate/salmeterol compared with inhaled corticosteroids.
Friedman HS; Yawn BP
Curr Med Res Opin; 2007 Feb; 23(2):427-34. PubMed ID: 17288696
[TBL] [Abstract][Full Text] [Related]
11. Quality assessment of reproductive health services.
McGlynn EA
West J Med; 1995 Sep; 163(3 Suppl):19-27. PubMed ID: 7571599
[TBL] [Abstract][Full Text] [Related]
12. Risk of asthma exacerbation, asthma-related health care utilization and costs, and adherence to controller therapy in patients with asthma receiving fluticasone propionate/salmeterol inhalation powder 100 μg/50 μg versus mometasone furoate inhalation powder.
Hagiwara M; Delea TE; Stanford RH
J Asthma; 2013 Apr; 50(3):287-95. PubMed ID: 23305687
[TBL] [Abstract][Full Text] [Related]
13. Relationship of asthma control to asthma exacerbations using surrogate markers within a managed care database.
Schatz M; Zeiger RS; Yang SJ; Chen W; Crawford WW; Sajjan SG; Allen-Ramey F
Am J Manag Care; 2010 May; 16(5):327-33. PubMed ID: 20469953
[TBL] [Abstract][Full Text] [Related]
14. Validity of the HEDIS criteria to identify children with persistent asthma and sustained high utilization.
Fuhlbrigge AL; Carey VJ; Finkelstein JA; Lozano P; Inui TS; Weiss ST; Weiss KB
Am J Manag Care; 2005 May; 11(5):325-30. PubMed ID: 15898221
[TBL] [Abstract][Full Text] [Related]
15. How well do the HEDIS asthma inclusion criteria identify persistent asthma?
Mosen DM; Macy E; Schatz M; Mendoza G; Stibolt TB; McGaw J; Goldstein J; Bellows J
Am J Manag Care; 2005 Oct; 11(10):650-4. PubMed ID: 16232006
[TBL] [Abstract][Full Text] [Related]
16. Double trouble: impact of inappropriate use of asthma medication on the use of health care resources.
Anis AH; Lynd LD; Wang XH; King G; Spinelli JJ; Fitzgerald M; Bai T; Paré P
CMAJ; 2001 Mar; 164(5):625-31. PubMed ID: 11258208
[TBL] [Abstract][Full Text] [Related]
17. Role of long-acting beta2-adrenergic agonists in asthma management based on updated asthma guidelines.
Prenner BM
Curr Opin Pulm Med; 2008 Jan; 14(1):57-63. PubMed ID: 18043276
[TBL] [Abstract][Full Text] [Related]
18. Evidence-based asthma management.
Kallstrom TJ
Respir Care; 2004 Jul; 49(7):783-92. PubMed ID: 15222910
[TBL] [Abstract][Full Text] [Related]
19. Association between previous health care use and initiation of inhaled corticosteroid and long-acting beta2-adrenergic agonist combination therapy among US patients with asthma.
Blanchette CM; Culler SD; Ershoff D; Gutierrez B
Clin Ther; 2009 Nov; 31(11):2574-83. PubMed ID: 20110003
[TBL] [Abstract][Full Text] [Related]
20. Multicolored simplified asthma guideline reminder (MSAGR) for better adherence to national/global asthma guidelines.
Ting S
Ann Allergy Asthma Immunol; 2002 Mar; 88(3):326-30. PubMed ID: 11926628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
